Human Factors Usability Studies Following ISO 62366 and FDA Guidance

This training program will examine how human factors/usability is the analysis of how people interact with medical devices. The process of conducting rigorous human factors studies throughout the design process, integrating it with the device risk analysis and design process and validating the effectiveness of the studies will be explained. The various types and methods of human factors analysis will be explained. This process conforms to the new ISO 62366 standard and the new FDA guidance document.

The FDA will only approve devices designed so that it is practically impossible for people to accidentally harm themselves even if they use the device improperly. The FDA has replaced the term "user error" with "user error," which means that it's how the product is used and not human error that is considered by the FDA to be a device nonconformity. As a result, human factors should be considered in the design process, and the burden is now on the device designer to create an "idiot proof" product.

Human Factors Usability Testing is an analysis of how people interact with medical devices. In this session, expert speaker Edwin Waldbusser will explain the process of conducting rigorous human factors studies throughout the design process, integrating it with the device risk analysis and design process, and validating the effectiveness of the studies. The various types and methods of human factors analysis will also be explained. This process conforms to the new ISO 62366 standard and the 2016 FDA guidance relating to it.

Edwin Waldbusser is a consultant retired from industry after 20 years of experience in the management of the development of medical devices (5 patients). He has been consulting in the areas of design control, risk analysis, and software validation for the past 8 years. He has a B.S. in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 lead auditor and a member of the Thomson Reuters Expert Witness network.